National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 2/10/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jeremy S. Abramson, MD

None

Genentech, Inc.;
Seattle Genetics, Inc.;
sanofi-aventis U.S.

None

None

4/16/2013

Ranjana H. Advani, MD

None

Celgene Corporation;
Genentech, Inc.;
Sanofi Oncology;
Seattle Genetics

None

None

9/21/2012

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

5/16/2013

Nancy Bartlett, MD

None

None

None

None

6/6/2012

Naresh Bellam, MD, MPH

None

None

None

None

2/9/2012

John C. Byrd, MD

None

None

None

None

3/26/2013

Myron S. Czuczman, MD

Celgene Corporation;
Cephalon, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

6/14/2012

Mary Dwyer, MS

None

None

None

None

3/26/2013

Luis E. Fayad, MD

Centocor, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Wyeth Pharmaceuticals

None

None

None

6/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Martha J. Glenn, MD

;
Piramal Life Sciences;
sanofi-aventis U.S.

None

None

None

1/9/2012

Jon P. Gockerman, MD

None

Novartis Pharmaceuticals Corporation

None

None

6/11/2012

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

6/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Nancy Lee Harris, MD

None

None

None

None

2/8/2012

Richard T. Hoppe, MD

None

None

None

None

2/28/2013

Steven M. Horwitz, MD

Celgene Corporation;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
;
Allos;
Gloucester;
Kiowa-Kirin;
Seattle Genetics;
Spectrum

Bristol-Myers Squibb Company;
Celgene Corporation;
Genzyme Corporation;
Merck & Co., Inc.;
Allos;
Kiowa-Kirin;
Seattle Genetics

None

None

3/19/2013

Christopher R. Kelsey, MD

None

None

None

None

3/5/2013

Youn H. Kim, MD

None

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Allos therapeutics;
Kyowa

None

None

3/10/2013

Susan Krivacic, MPAff

None

None

None

None

2/11/2013

Ann S. LaCasce, MD

None

None

None

None

3/4/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Auayporn Nademanee, MD

Seattle Genetics Co.

None

None

None

3/15/2013

Maoko Naganuma, MSc

None

None

None

GlaxoSmithKline

2/28/2013

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

3/4/2013

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.;
Algeta;
Allos;
Emergent Biosolutions;
Seattle Genetics;
Roche Laboratories, Inc.

Emergent Biosolutions

FujiFilm

5/2/2013

Barbara Pro, MD

None

Celgene Corporation;
allos

None

None

1/17/2012

Nishitha Reddy, MD

None

None

None

None

5/10/2013

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Celgene Corporation;
Eisai Inc.;
MedImmune Inc.;
Allos

None

None

3/4/2013

Lode J. Swinnen, MB, ChB

None

None

None

None

6/6/2012

Christina Tsien, MD

None

None

None

None

3/5/2013

Julie M. Vose, MD

None

None

None

None

3/5/2013

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

3/4/2013

Joachim Yahalom, MD

None

None

None

None

2/8/2012

Nadeem Zafar, MD

None

None

None

None

10/8/2012

Andrew D. Zelenetz, MD, PhD

None

Abbott Laboratories;
Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
Seattle Genetics;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

2/15/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved